TrialMedicine2026

Application of high-flux hemodialysis combined with hypoxia-inducible factor prolyl hydroxylase inhibitor in the treatment of renal anemia in patients with uremia: A randomized controlled trial.

Jiajia Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.